ZUGA MATT (Chief Financial Officer) sold 1.3% of their position (4.16K shares) of ACUMEN PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/23/2026ACC: 0001628280-26-003347
Officer· Chief Financial Officer
Since Jun 2021
-4.16K
Net shares
Net seller
$7.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.47K
Price / share
$1.81
Trade value
$4.47K
% of position
0.8%
1/21/2026
309.08K→306.61K
Common Stock
Direct
Shares
−1.69K
Price / share
$1.86
Trade value
$3.14K
% of position
0.6%
1/22/2026
306.61K→304.92K
Total
Net shares
−4.16K
Net value
-$7.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | S · Sale | −2.47K | $1.81 | $4.47K | 0.8% | 309.08K | 306.61K |
| Common Stock Direct | 1/22/2026 | S · Sale | −1.69K | $1.86 | $3.14K | 0.6% | 306.61K | 304.92K |
| Total | −4.16K | -$7.61K | ||||||
Derivative Transactions0
No derivative transactions reported